Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

NCT02165111 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Johns Hopkins University

Collaborators